Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Celsing

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Blood|March 15, 1993
Natural interferon-alpha in combination with melphalan/prednisone versus melphalan/prednisone in the treatment of multiple myeloma stages II and III: a randomized study from the Myeloma Group of Central SwedenA Osterborg, M Björkholm, M Björeman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphomaF Celsing, S Widell, K Merk, et al.
European Journal of Haematology|July 1, 1993
Etoposide, doxorubicin, cyclophosphamide and high-dose betamethasone (EACB) as outpatient salvage therapy for refractory multiple myelomaM Ohrling, M Björkholm, A Osterborg, et al.
British Journal of Cancer|August 30, 2007
Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemiaA Olsson, M Norberg, A Okvist, et al.
Leukemia|September 13, 2003
No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative diseaseR Hast, E Hellström-Lindberg, L Ohm, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Blood|March 15, 1993
Natural interferon-alpha in combination with melphalan/prednisone versus melphalan/prednisone in the treatment of multiple myeloma stages II and III: a randomized study from the Myeloma Group of Central SwedenA Osterborg, M Björkholm, M Björeman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphomaF Celsing, S Widell, K Merk, et al.
European Journal of Haematology|July 1, 1993
Etoposide, doxorubicin, cyclophosphamide and high-dose betamethasone (EACB) as outpatient salvage therapy for refractory multiple myelomaM Ohrling, M Björkholm, A Osterborg, et al.
British Journal of Cancer|August 30, 2007
Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemiaA Olsson, M Norberg, A Okvist, et al.
Leukemia|September 13, 2003
No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative diseaseR Hast, E Hellström-Lindberg, L Ohm, et al.
Pageof 4